NASDAQ · SERVICES-HELP SUPPLY SERVICES · MID CAP
Cross Country Healthcare Inc. CCRN
17 fiscal years on record · USD · FY2025 reported · SEC filings only
In brief
What this company does
Written from the business description in Cross Country Healthcare, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 9 March 2026. Every sentence was checked against that document before publication.
Growth
USD 1.1B
Revenue, FY2025 · full 17-year series below
Revenue $B
Net income $B
FY2025 · Revenue 1.1 · Net income -0.1
Compound annual growth
Revenue compounded at +4.7% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−9 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating -8.0% · Net -9.0%
ROE
FY2025 · ROE -25.6%
Each USD of equity lost 26 cents this year.
The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 1.1 | 1.3 | 2.0 | 2.8 | 1.7 | 0.8 | 0.8 | 0.8 | 0.9 | 0.8 | 0.8 | 0.6 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 |
| Operating income $B | −0.1 | −0.0 | 0.1 | 0.3 | 0.1 | −0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | 0.0 |
| EBITDA $B | −0.1 | 0.0 | 0.1 | 0.3 | 0.1 | 0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 |
| Income tax $B | 0.0 | −0.0 | 0.0 | 0.1 | 0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | −0.0 | 0.0 | 0.0 | −0.0 | 0.0 | −0.0 | 0.0 |
| Net income $B | −0.1 | −0.0 | 0.1 | 0.2 | 0.1 | −0.0 | −0.1 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.1 | −0.0 | 0.0 | −0.0 | 0.0 |
| Free cash flow $B | 0.0 | 0.1 | 0.2 | 0.1 | −0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| EPS, diluted $ | −2.93 | −0.44 | 2.05 | 4.95 | 3.53 | −0.36 | −1.61 | −0.48 | 1.01 | 0.15 | 0.14 | −1.02 | −1.68 | −1.37 | 0.13 | −0.09 | 0.22 |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
| ROE % | −25.6 | −3.3 | 15.8 | 50.5 | 58.8 | −8.2 | −30.4 | −7.5 | 19.3 | 5.5 | 3.3 | −21.9 | −28.1 | −18.4 | 1.7 | −1.1 | 2.7 |
| Shares out B | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 66 reconciliationsAUDITED
Reconciled in 17 of 19 fiscal years. 12 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Help Supply Services
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2009